<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01214408</url>
  </required_header>
  <id_info>
    <org_study_id>R12-576</org_study_id>
    <nct_id>NCT01214408</nct_id>
  </id_info>
  <brief_title>Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hydrogen (pH) in Patients From Acid Peptic Disorder After Single and Repeated Dosing.</brief_title>
  <official_title>Effect of Digene Total on 24 Hrs Ambulatory Gastric ph in Pts Suffering From Acid Peptic Disorder After Single and Repeated Dosing.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, open label, single-center and non-comparative study is designed to generate
      data on Digene Total's (buffered pantoprazole) rapid and sustained gastric acid inhibition
      effect in patients suffering from acid peptic disorders.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time taken to achieve a gastric pH of &gt; 4 after a single dose of Digene Total (buffered pantoprazole)</measure>
    <time_frame>Assessment done on day 1 for group A subjects</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of time gastric pH was &gt; 4 after repeated dosing of Digene Total (buffered pantoprazole)</measure>
    <time_frame>Assessment done on day 7 for all subjects</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24 hour median gastric pH after repeated dosing of Digene Total (buffered pantoprazole)</measure>
    <time_frame>Assessment done on day 1 for group A subjects</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Acid Peptic Disorder</condition>
  <arm_group>
    <arm_group_label>GRP-A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>GRP-B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Buffered pantoprazole</intervention_name>
    <description>Buffered pantoprazole 40 mg QD</description>
    <arm_group_label>GRP-A</arm_group_label>
    <other_name>ABT-897, Buffered Pantoprazole, Digene Total</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Buffered pantoprazole</intervention_name>
    <description>Buffered pantoprazole 40 mg QD</description>
    <arm_group_label>GRP-B</arm_group_label>
    <other_name>ABT-897, Buffered Pantoprazole, Digene Total</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult subjects (18-65 years) suffering from acid peptic disorder (APD), diagnosed
             endoscopically (reflux esophagitis, gastritis and peptic ulcer)

          2. Must voluntarily sign and date an informed consent form, approved by an Independent
             Ethics Committee (IEC)/ Institutional Review Board (IRB), prior to any study specific
             procedures.

          3. If female, subject must be either postmenopausal for at least 1 year, surgically
             sterile (bilateral tubal ligation, bilateral oophorectomy or hysterectomy), or
             practicing at least one of the following methods of birth control:

               1. Total abstinence from sexual intercourse (minimum one completed menstrual cycle)

               2. A vasectomized partner

               3. Hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months
                  prior to study drug administration.

               4. Intrauterine device (IUD)

               5. Double barrier method (condoms, contraceptive sponge, diaphragm or vaginal ring
                  with spermicidal jellies or creams)

        Exclusion Criteria:

          1. Subjects with concurrent gastrointestinal diseases, gastric surgery, perforation or
             bleeding

          2. Subjects who have a history of use of any antisecretory drug within past 7 days prior
             study Day 0

          3. Subjects with cardiac, neurological, renal or hepatic dysfunction

          4. Past history of significant sensitivity or contraindication to study drug

          5. Pregnant or breast-feeding female

          6. Any condition that, in the opinion of the Investigator, does not justify the subject's
             inclusion for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Balagopal Nair, MD</last_name>
    <role>Study Director</role>
    <affiliation>Abbott India Ltd</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Site Reference ID/Investigator# 42043</name>
      <address>
        <city>Chennai</city>
        <zip>600 096</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <link>
    <url>http://dailymed.nlm.nih.gov/dailymed/about.cfm</url>
    <description>For more information, click on the website link</description>
  </link>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2010</study_first_submitted>
  <study_first_submitted_qc>October 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2010</study_first_posted>
  <last_update_submitted>December 26, 2012</last_update_submitted>
  <last_update_submitted_qc>December 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pantoprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

